Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism HIF-2α inhibitors(Endothelial PAS domain-containing protein 1 inhibitors), VEGF inhibitors(Vascular endothelial growth factor inhibitors), VHL inhibitors(von Hippel-Lindau tumor suppressor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Digestive System Disorders | Discovery | - | 03 Oct 2023 | |
Immune System Diseases | Discovery | - | 03 Oct 2023 | |
Neoplasms | Discovery | - | 03 Oct 2023 | |
Nephritis | Discovery | - | 03 Oct 2023 | |
Other Diseases | Discovery | - | 03 Oct 2023 | |
Pneumonia | Discovery | - | 03 Oct 2023 | |
Skin and Musculoskeletal Diseases | Discovery | - | 03 Oct 2023 | |
Surgical Wound Infection | Discovery | - | 03 Oct 2023 |